|
YBX1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
6.99040000329276E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
4.88498130835069E-15 |
| Stage1-vs-Stage2 |
9.041600E-01 |
| Stage1-vs-Stage3 |
1.336160E-01 |
| Stage1-vs-Stage4 |
3.905600E-01 |
| Stage2-vs-Stage3 |
4.710000E-01 |
| Stage2-vs-Stage4 |
6.305400E-01 |
| Stage3-vs-Stage4 |
7.764600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.844500E-04 |
| Normal-vs-Asian |
1.23812071706197E-12 |
| Caucasian-vs-AfricanAmerican |
4.994400E-02 |
| Caucasian-vs-Asian |
1.465010E-01 |
| AfricanAmerican-vs-Asian |
2.823800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62658775337832E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
2.766600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
8.00470800754738E-14 |
| Normal-vs-Age(81-100Yrs) |
4.284400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.588400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.918200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.127200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.700400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.500200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.314400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.973980E-02 |
| Classical-VS-Follicular |
9.835400E-01 |
| Classical-VS-Other |
9.832400E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
5.520500E-02 |
| Tall-VS-Other |
4.709600E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
9.777800E-01 |
| Follicular-VS-Normal |
3.89890342233912E-11 |
| Other-VS-Normal |
5.507900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
5.660100E-02 |
|
|
